Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
Κύριοι συγγραφείς: | Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR |
---|---|
Μορφή: | Conference item |
Έκδοση: |
2011
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
ανά: Gillies, R, κ.ά.
Έκδοση: (2012) -
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
ανά: Gillies, R, κ.ά.
Έκδοση: (2012) -
XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
ανά: Hatch, S, κ.ά.
Έκδοση: (2014) -
Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
ανά: Graf, Nora, κ.ά.
Έκδοση: (2012) -
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
ανά: MacGregor, T, κ.ά.
Έκδοση: (2018)